MeningiomaNCT02267928
Information Presentation Formats
A study testing Check Symptoms, Uncheck Symptoms and Experienced in people with Meningioma, run by Carnegie Mellon University at 1 site in United States.
Trial summary
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. Read more about this study
- Who is it for?
- Ages 18 years and olderHealthy volunteers can take part
- Conditions the study is for
- Meningioma
- What is being tested?
- Check Symptoms, Uncheck Symptoms and Experienced
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 305 participants
- Where
- 1 siteUnited States
- Study dates
- Oct 2014to May 2016
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- 18 or older
- American
Who cannot join
- Mechanical Turk approval rate below 95%
Trial locations and contacts
1 site in 1 country.
United States1 site
Carnegie Mellon University
Pittsburgh, Pennsylvania, 15213
About this study
Official title: Information Presentation Formats and Pursuit of Diagnostic Information
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
Read the detailed description
We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).
- Conditions
- Meningioma
- Being tested
- Check Symptoms, Uncheck Symptoms, Experienced, Not Experienced
- Keywords
- Symptom Assessment
- Medical subject headings
- Meningioma
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Check SymptomsOther
Symptoms are "Checked"
Uncheck SymptomsOther
Symptoms are "Un-checked"
ExperiencedOther
Focus of instructions is on symptoms the participant has experienced
Not ExperiencedOther
Focus of instructions is on symptoms the participant has NOT experienced
| Study group | Role | What they receive |
|---|---|---|
| Check/Experience | Experimental | Participants are asked to check the symptoms that they have experienced in the last 6 weeks. Receives: Other: Check Symptoms; Other: Experienced |
| Un-check/Experience | Experimental | Participants are asked to un-check the symptoms that they have experienced in the last 6 weeks. Receives: Other: Uncheck Symptoms; Other: Experienced |
| Check/Not Experienced | Experimental | Participants are asked to check the symptoms that they have NOT experienced in the last 6 weeks. Receives: Other: Check Symptoms; Other: Not Experienced |
| Un-check/Not Experienced | Experimental | Participants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks. Receives: Other: Uncheck Symptoms; Other: Not Experienced |
What is being measured
The primary outcome is the main question the study is designed to answer.
Number of symptoms
The number of symptoms checked off by participants
Measured: 1 day
Risk of meningioma
Self-reported perceived risk of meningioma
Measured: 1 day
Information pursuit
Binary measure of whether participants click to receive information about meningioma
Measured: 1 day
Secondary outcomes (2)
Funding allocation
Hypothetical federal funding allocation to meningioma
Measured: 1 day
Risk of serious disease
Perceived risk of having any serious disease
Measured: 1 day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted20 Oct 2014 (estimated)
- Study startOct 2014
- Primary completionMar 2016
- Study completionMay 2016
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for MeningiomaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 305 participants (actual)
Sponsor and investigators
- Lead sponsor
- Carnegie Mellon University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Eric VanEpps, Carnegie Mellon University
- Investigators
- Eric M VanEpps, MS, Principal investigator, Carnegie Mellon University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT02267928
- Sponsor's protocol ID
- HS14-574
- Status last verified
- Aug 2016
- First submitted
- 14 Oct 2014
- Last updated
- 2 Aug 2016
- Results posted
- No
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 2 Aug 2016. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Information Presentation Formats and Pursuit of Diagnostic Information
- ClinicalTrials.gov ID
- NCT02267928
- Acronym / sponsor ID
- HS14-574
- Conditions
- Meningioma
- Keywords
- Symptom Assessment
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 305 participants (actual)
- Lead sponsor
- Carnegie Mellon UniversityUniversity, hospital or other
- Study start
- Oct 2014
- Primary completion
- Mar 2016 (actual)
- Study completion
- May 2016 (actual)
- First posted
- 20 Oct 2014 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Prevention and early detection of medical problems can greatly reduce health care costs, yet time and again, people avoid or ignore services that could help detect medical problems early enough to prevent or reduce the severity of potential problems. The investigators seek to understand whether the elicitation of symptom admission by patients can predict people's perceived risk of the medical condition and voluntary pursuit of medical information.
Detailed description
We will present individuals with medically accurate information about a medical condition and measure people's perceptions of their own likelihood to having that medical condition. This will include an opportunity for people to pursue more information by directing them to a website that features more information about the condition. The initial information provision will vary slightly in presentation (method of eliciting symptoms will vary), and the rate at which individuals visit the subsequent medical website to receive more information will be recorded as a measure of information seeking behavior. Rates will be compared across symptom elicitation conditions to determine which formats are most effective at encouraging information seeking about health issues. No personally identifying information will be collected, and all results will be reported in aggregate. Critically, no deception will be used: Participants will only be provided with information that is as accurate as possible (given existing knowledge in the health/medical fields).
Study design
- Primary purpose
- Screening
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind (participant)
- Number of arms
- 4
| Arm | Type | Receives |
|---|---|---|
| Check/Experience | Experimental | Other: Check Symptoms, Other: ExperiencedParticipants are asked to check the symptoms that they have experienced in the last 6 weeks. |
| Un-check/Experience | Experimental | Other: Uncheck Symptoms, Other: ExperiencedParticipants are asked to un-check the symptoms that they have experienced in the last 6 weeks. |
| Check/Not Experienced | Experimental | Other: Check Symptoms, Other: Not ExperiencedParticipants are asked to check the symptoms that they have NOT experienced in the last 6 weeks. |
| Un-check/Not Experienced | Experimental | Other: Uncheck Symptoms, Other: Not ExperiencedParticipants are asked to un-check the symptoms that they have NOT experienced in the last 6 weeks. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- 18 or older
- American
Key exclusion criteria (1 listed)
- Mechanical Turk approval rate below 95%
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Check SymptomsSymptoms are "Checked" | Other | Check/Experience, Check/Not Experienced |
| Uncheck SymptomsSymptoms are "Un-checked" | Other | Un-check/Experience, Un-check/Not Experienced |
| ExperiencedFocus of instructions is on symptoms the participant has experienced | Other | Check/Experience, Un-check/Experience |
| Not ExperiencedFocus of instructions is on symptoms the participant has NOT experienced | Other | Check/Not Experienced, Un-check/Not Experienced |
Primary outcome
Number of symptoms
Time frame: 1 day
The number of symptoms checked off by participants
Risk of meningioma
Time frame: 1 day
Self-reported perceived risk of meningioma
Information pursuit
Time frame: 1 day
Binary measure of whether participants click to receive information about meningioma
2 secondary outcomes
Funding allocation
Time frame: 1 day
Risk of serious disease
Time frame: 1 day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 2 Aug 2016.
Related trials for Meningioma
RecruitingPhase 2
A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma
Meningioma
Not yet recruitingPhase 2
Selumetinib for NF2-Related Schwannomatosis
Neurofibromatosis Type 2, NF2
RecruitingPhase 2
A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma
Meningioma
RecruitingPhase 2
Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)
Neurofibromatosis Type 2, Vestibular Schwannoma
Active, not recruitingPhase 2
Enhancement of Neurocognitive Functions by Hippocampal Sparing Radiotherapy
Radiation of Neurocranial Region
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Eric M VanEpps, MS principal investigator
Carnegie Mellon University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Check Symptoms, Uncheck Symptoms and Experienced in people with Meningioma, run by Carnegie Mellon University at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 2 Aug 2016. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Number of symptoms (time frame: 1 day). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Aug 2016.